What happens when a seemingly harmless flu turns into a silent threat to your heart? Every year, millions battle common viruses like influenza or COVID-19, often shrugging them off as temporary inconveniences, yet beneath the surface, these infections may be laying the groundwork for something far
Every year, millions of lives are at stake due to delays in diagnosing severe heart attacks, particularly ST-segment elevation myocardial infarction (STEMI), a critical condition caused by a blocked coronary artery, and the difference between life and death often hinges on mere minutes. Timely
In the ever-evolving battle against cancer, a new frontier has emerged that promises to transform the landscape of treatment, particularly for stubborn solid tumors such as those found in breast, colorectal, pancreatic, and lung cancers. Natural Killer (NK) cell therapies, leveraging a unique
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology, innovation, and research and development within the industry. Today, we’re diving into the exciting world of biomanufacturing, focusing on a groundbreaking new lab at a prominent
Imagine a silent threat lingering in the air, one that could be contributing to a major health crisis for women across the United States, where recent research has uncovered a startling connection between air pollution and an increased risk of breast cancer. This disease remains the second leading
Taiwan is carving out a formidable reputation in the global biotech arena, and its participation in BioJapan 2025, taking place from October 8-10 at PACIFICO Yokohama in Yokohama, Japan, is a testament to this ascent. Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO),
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology and innovation within the industry. With a strong background in research and development, Ivan has been at the forefront of integrating cutting-edge solutions like machine learning into
Synthetic biology, an innovative discipline that merges biology, engineering, and data science, is fundamentally altering the landscape of industry and healthcare with its remarkable potential for tailored solutions. No longer confined to research labs, this field is becoming a critical tool for
The landscape of medical treatment has been profoundly transformed by biologics—complex therapies like monoclonal antibodies, recombinant proteins, and nucleic acid-based solutions that target diseases with remarkable precision. Despite their groundbreaking impact, a significant challenge persists:
In the face of a potential extended federal government shutdown, U.S. healthcare providers are grappling with unprecedented challenges that could disrupt everything from patient care to financial stability, prompting urgent strategic planning. A recent flash survey conducted among 152 healthcare
